trimethoprim has been researched along with fosfomycin in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (24.49) | 18.7374 |
1990's | 6 (12.24) | 18.2507 |
2000's | 10 (20.41) | 29.6817 |
2010's | 16 (32.65) | 24.3611 |
2020's | 5 (10.20) | 2.80 |
Authors | Studies |
---|---|
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Awuah, E; Barker, C; Brown, ED; Capretta, FA; Das, R; Gerritsma, DA; Lebert, J; Melacini, G; Pathania, R; Zlitni, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Allison, SE; Barker, CA; Brown, ED; Capretta, AA; Das, R; Melacini, G; Nguyen, ND; Zlitni, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Inamatsu, T | 1 |
Barry, AL; Fuchs, PC | 1 |
Harvard Davis, R; Holmes, W; O'Dowd, TC; Slack, RC; Smail, J | 1 |
Chisari, G; Gismondo, MR; Lo Bue, AM; Nicoletti, G; Romeo, MA | 1 |
Fontana, R; Meloni, GA; Rossi, L | 1 |
Dubini, F; Riviera, L | 2 |
Dubini, F; Riviera, L; Visconti, A | 1 |
Fontana, P; Lamanna, S; Novelli, A; Periti, P; Reali, EF | 2 |
Albini, E; Belluco, G; Marca, G | 1 |
Greenwood, D; Slack, R | 1 |
Borsotto, M; Carlone, NA; Cuffini, AM; Savoia, D | 1 |
Hitzig, WH; Höger, PH; Schaad, UB; Seger, RA | 1 |
Kamimura, T; Neu, HC | 1 |
Konishi, H; Morshed, MG; Nakazawa, T; Nishimura, T | 1 |
Bovill, B; Chattopadhyay, D; Duckworth, GJ; Lewis, DA; Minassian, MA; Williams, JD | 1 |
Janknegt, R; Kullberg, BJ; Stobberingh, E; van den Broek, PJ | 1 |
Nagatomo, H; Nagayoshi, M; Sueyoshi, M; Uemura, R | 1 |
Shaikh, N; Tarr, PI | 1 |
Lobel, B | 1 |
Martínez-Ruiz, R; Millán-Pérez, R; Orden-Martínez, B | 1 |
Blázquez, J; López, E | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
Burian, A; Erdogan, Z; Jandrisits, C; Zeitlinger, M | 1 |
Bleidorn, J; Gágyor, I; Hummers-Pradier, E; Schmiemann, G | 1 |
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
Ahmad Murad, K; Chen, YT; Ng, LS; Park, JJ; Seah, JT; Tan, TY | 1 |
Caron, F; Etienne, M; Wehrle, V | 1 |
Dubourg, G; Gales, AC; Kaye, KS | 1 |
Eliakim-Raz, N; Leibovici, L; Paul, M; Zayyad, H | 1 |
Hidaka, Y; Masuzawa, T; Saito, M; Sakakibara, K; Villanueva, SYAM; Yanagihara, Y; Yoshida, SI | 1 |
Beigi, RH; Bradley, MS; Shepherd, JP | 1 |
Bonten, MJM; Koch, BCP; Ten Doesschate, T; van Haren, E; van Werkhoven, CH; Wijma, RA | 1 |
Karakonstantis, S | 1 |
Ten Doesschate, T | 1 |
Abouwarda, AM; Mohamed Abu El-Wafa, W | 1 |
Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
6 review(s) available for trimethoprim and fosfomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Choice of antibiotics in uncomplicated cystitis; application of 'system of objectified judgement analysis' (SOJA) method].
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Cystitis; Delayed-Action Preparations; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Trimethoprim | 1999 |
Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fosfomycin; Humans; Longitudinal Studies; Meta-Analysis as Topic; Nitrofurantoin; Norfloxacin; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2003 |
The comeback of trimethoprim in France.
Topics: Anti-Bacterial Agents; Cystitis; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Fosfomycin; France; Humans; Practice Guidelines as Topic; Product Recalls and Withdrawals; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2017 |
Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Sulfamethizole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Revival of old antibiotics: needs, the state of evidence and expectations.
Topics: Amdinocillin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Evidence-Based Medicine; Fosfomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nitrofurantoin; Staphylococcal Skin Infections; Sulfamethizole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
5 trial(s) available for trimethoprim and fosfomycin
Article | Year |
---|---|
A comparative double-blind randomised study of single dose fosfomycin trometamol with trimethoprim in the treatment of urinary tract infections in general practice.
Topics: Double-Blind Method; Drug Administration Schedule; Family Practice; Female; Fosfomycin; Humans; Trimethoprim; Urinary Tract Infections | 1990 |
[Chemoprevention using fosfomycin trometamol in transurethral resection of the prostate: multicenter controlled clinical study].
Topics: Amoxicillin; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Fosfomycin; Humans; Male; Postoperative Complications; Premedication; Prostate; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Combinations; Fosfomycin; Humans; Male; Premedication; Prospective Studies; Prostatectomy; Random Allocation; Sulfamethoxazole; Surgical Wound Infection; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
The microbiological and pharmacokinetic profile of an antibacterial agent useful for the single-dose therapy of urinary tract infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infections; Fosfomycin; Humans; Kinetics; Lactams; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Citrobacter; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Family Practice; Female; Fosfomycin; Humans; Klebsiella; Microbial Sensitivity Tests; Middle Aged; Proteus mirabilis; Staphylococcal Infections; Staphylococcus; Trimethoprim; United Kingdom; Urinary Tract Infections | 1998 |
38 other study(ies) available for trimethoprim and fosfomycin
Article | Year |
---|---|
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.
Topics: Anti-Bacterial Agents; Cell Division; Chromatography, Liquid; Cycloserine; Doxorubicin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Genes, Bacterial; Genome, Bacterial; Genomics; Lipoproteins; Mass Spectrometry; Molecular Chaperones; Periplasmic Binding Proteins; Pseudomonas aeruginosa; Sulfamethoxazole; Suppression, Genetic; Trimethoprim | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Molecular Chaperones; Periplasmic Binding Proteins; Structure-Activity Relationship; Thiourea | 2013 |
[Chemotherapy of MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Combinations; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin | 1992 |
In vitro susceptibility testing procedures for fosfomycin tromethamine.
Topics: Bacteria; Fosfomycin; Glucose-6-Phosphate; Glucosephosphates; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
Topics: Bacteria; Cystitis; Drug Combinations; Escherichia coli; Fosfomycin; Humans; Microbial Sensitivity Tests; Pipemidic Acid; Pseudomonas aeruginosa; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens.
Topics: Bacteria; Drug Combinations; Drug Resistance, Microbial; Fosfomycin; Humans; Microbial Sensitivity Tests; Mutation; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Urine | 1988 |
Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
Topics: Administration, Oral; Adolescent; Adult; Bacteria; Cystitis; Drug Combinations; Fosfomycin; Humans; Male; Models, Biological; Norfloxacin; Pipemidic Acid; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 1988 |
Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol.
Topics: Administration, Oral; Animals; Bacterial Infections; Cystitis; Drug Combinations; Fosfomycin; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol].
Topics: Animals; Cystitis; Drug Combinations; Drug Evaluation, Preclinical; Escherichia coli Infections; Fosfomycin; Klebsiella Infections; Norfloxacin; Pipemidic Acid; Proteus Infections; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
Topics: Culture Media; Drug Combinations; Escherichia coli; Fosfomycin; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 1986 |
Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents.
Topics: Bacterial Adhesion; Drug Combinations; Escherichia coli; Fosfomycin; Hemagglutination; Humans; Microbial Sensitivity Tests; Norfloxacin; Proteus mirabilis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Biological Transport, Active; Chemotaxis, Leukocyte; Child; Child, Preschool; Female; Fosfomycin; Granulocytes; Granulomatous Disease, Chronic; Humans; Intracellular Fluid; Male; Middle Aged; Neutrophils; Penicillins; Phagocytosis; Rifampin; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim | 1985 |
In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Carbenicillin; Cephalexin; Culture Media; Fosfomycin; Male; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Sulfamethoxazole; Trimethoprim | 1981 |
Evaluation of agents for use in medium for selective isolation of Lyme disease and relapsing fever Borrelia species.
Topics: Bacteriological Techniques; Borrelia; Culture Media; Drug Combinations; Fluorouracil; Fosfomycin; Lyme Disease; Microbial Sensitivity Tests; Relapsing Fever; Trimethoprim | 1993 |
Antimicrobial susceptibilities of Shiga toxin-producing Escherichia coli isolates from pigs with edema disease in Japan.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bridged Bicyclo Compounds, Heterocyclic; Edema Disease of Swine; Escherichia coli; Escherichia coli Infections; Fosfomycin; Japan; Lactams; Microbial Sensitivity Tests; Novobiocin; Peptides; Swine; Tetracyclines; Trimethoprim | 2003 |
Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Bile Acids and Salts; Chromosome Mapping; Ciprofloxacin; Escherichia coli O157; Fosfomycin; Genome, Bacterial; Molecular Sequence Data; Recombination, Genetic; Shiga Toxin; Shiga Toxin 1; Shiga Toxin 2; Sulfamethoxazole; Trimethoprim; Virulence; Virus Integration | 2003 |
[What are we learning about Staphylococcus saprophyticus?].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Contraindications; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Fosfomycin; Humans; Male; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Spain; Staphylococcal Infections; Staphylococcus; Sulfamethizole; Trimethoprim; Urinary Tract Infections; Young Adult | 2008 |
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim | 2009 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Colistin; Ertapenem; Fosfomycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Trimethoprim; Urine | 2012 |
Resistance profiles of urinary tract infections in general practice--an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fosfomycin; General Practice; Germany; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Prospective Studies; Trimethoprim; Urinary Tract Infections; Young Adult | 2012 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Genotype; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillins; Singapore; Trimethoprim; Urinary Tract Infections | 2016 |
Characterization of Leptospira species isolated from soil collected in Japan.
Topics: Amphotericin B; DNA, Bacterial; DNA, Ribosomal; Fluorouracil; Fosfomycin; Japan; Leptospira; Phylogeny; Sequence Analysis, DNA; Soil; Soil Microbiology; Sulfamethoxazole; Trimethoprim | 2018 |
A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
Topics: Anti-Bacterial Agents; Costs and Cost Analysis; Decision Trees; Drug Combinations; Dysuria; Female; Fosfomycin; Humans; Nitrofurantoin; Postmenopause; Sulfamethizole; Trimethoprim; Urinalysis; Urinary Tract Infections | 2019 |
The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacteria; Cystitis; Female; Fosfomycin; Glomerular Filtration Rate; Humans; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Treatment Failure; Trimethoprim; Urinary Bladder; Urinary Tract Infections | 2020 |
Re: 'The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function' by ten Doesschate et al.
Topics: Anti-Bacterial Agents; Cystitis; Fosfomycin; Humans; Nitrofurantoin; Trimethoprim | 2020 |
'The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function' - Author's reply.
Topics: Anti-Bacterial Agents; Cystitis; Fosfomycin; Humans; Nitrofurantoin; Trimethoprim | 2020 |
In vitro assessment of the antibacterial effects of the combinations of fosfomycin, colistin, trimethoprim and nitrofurantoin against multi-drug-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Fosfomycin; Microbial Sensitivity Tests; Nitrofurantoin; Pharmaceutical Preparations; Trimethoprim | 2022 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |